The University of Chicago Header Logo

Mary Eileen Dolan

Concepts (798)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Guanine
82
2011
208
8.270
Why?
Antineoplastic Agents
67
2023
2347
6.770
Why?
Cisplatin
37
2023
604
6.670
Why?
Pharmacogenetics
40
2022
429
6.400
Why?
Polymorphism, Single Nucleotide
68
2020
2345
5.910
Why?
O(6)-Methylguanine-DNA Methyltransferase
80
2011
118
4.420
Why?
Genome-Wide Association Study
48
2022
1601
4.210
Why?
Peripheral Nervous System Diseases
10
2022
85
4.110
Why?
Drug Resistance, Neoplasm
30
2021
589
3.230
Why?
Genetic Variation
27
2019
1346
2.810
Why?
Genome, Human
25
2018
754
2.770
Why?
Neoplasms
26
2022
2868
2.700
Why?
Tinnitus
5
2023
21
2.680
Why?
Testicular Neoplasms
7
2023
104
2.590
Why?
Methyltransferases
50
2008
181
2.500
Why?
Antineoplastic Agents, Alkylating
24
2015
138
2.480
Why?
Quantitative Trait Loci
22
2017
568
2.380
Why?
Hearing Loss
6
2023
51
2.330
Why?
Drug-Related Side Effects and Adverse Reactions
8
2020
197
2.330
Why?
Cancer Survivors
6
2023
84
2.070
Why?
Antineoplastic Agents, Phytogenic
12
2015
276
2.040
Why?
Cell Line, Tumor
36
2019
2416
2.030
Why?
Cell Line
40
2018
2462
1.860
Why?
Carboplatin
13
2018
286
1.830
Why?
Paclitaxel
10
2018
458
1.820
Why?
Gene Expression
16
2014
1279
1.780
Why?
Carmustine
34
2007
70
1.750
Why?
Neurotoxicity Syndromes
3
2022
28
1.740
Why?
Antineoplastic Combined Chemotherapy Protocols
27
2021
2424
1.720
Why?
Humans
232
2023
85610
1.710
Why?
Cyclophosphamide
12
2014
299
1.680
Why?
Gene Expression Regulation
12
2021
1903
1.680
Why?
Lymphocytes
9
2018
459
1.640
Why?
Apoptosis
13
2014
1676
1.570
Why?
Dacarbazine
18
2014
102
1.550
Why?
Antimetabolites, Antineoplastic
9
2020
236
1.540
Why?
Induced Pluripotent Stem Cells
5
2021
101
1.450
Why?
MicroRNAs
7
2018
534
1.420
Why?
Cell Proliferation
9
2012
1568
1.350
Why?
Drug Discovery
4
2012
103
1.230
Why?
Enzyme Inhibitors
24
2009
631
1.210
Why?
Etoposide
8
2021
195
1.210
Why?
Polymorphism, Genetic
15
2015
819
1.170
Why?
Precision Medicine
5
2017
390
1.150
Why?
DNA Repair
28
2007
356
1.150
Why?
Gene Expression Regulation, Neoplastic
13
2020
1196
1.140
Why?
Cytarabine
7
2020
218
1.110
Why?
Neurons
6
2021
1545
1.110
Why?
Cell Survival
21
2019
966
1.100
Why?
Alkylating Agents
7
2008
32
1.080
Why?
Vincristine
3
2021
111
1.070
Why?
Genotype
22
2020
1845
1.060
Why?
Gene Expression Profiling
13
2021
1378
0.990
Why?
Disease Susceptibility
2
2019
191
0.990
Why?
Camptothecin
7
2009
189
0.980
Why?
Glutathione Transferase
5
2009
111
0.950
Why?
Tumor Cells, Cultured
33
2005
1039
0.910
Why?
Biomarkers, Tumor
6
2020
1458
0.910
Why?
Brain Neoplasms
13
2014
762
0.890
Why?
Genetic Predisposition to Disease
15
2019
2254
0.880
Why?
Speech Perception
1
2022
71
0.850
Why?
Cytosine
6
2015
127
0.840
Why?
Pemetrexed
3
2018
76
0.840
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
2021
366
0.840
Why?
HapMap Project
9
2014
47
0.830
Why?
Ribonucleoproteins, Small Nuclear
1
2021
20
0.820
Why?
Genes
2
2013
305
0.820
Why?
Cytochrome P-450 Enzyme System
5
2015
79
0.800
Why?
Leukemia, Myeloid, Acute
8
2020
751
0.780
Why?
Daunorubicin
4
2014
78
0.780
Why?
Organoplatinum Compounds
3
2011
94
0.770
Why?
Phenotype
16
2015
2362
0.770
Why?
Cell Cycle Proteins
3
2017
386
0.760
Why?
Nuclear Proteins
5
2015
691
0.740
Why?
Colistin
2
2017
7
0.730
Why?
DNA, Neoplasm
7
2006
265
0.720
Why?
Population Groups
2
2010
41
0.720
Why?
Biomarkers, Pharmacological
4
2012
22
0.720
Why?
Genetic Linkage
4
2008
622
0.710
Why?
Transcription Factors
9
2017
1534
0.690
Why?
Membrane Proteins
5
2018
1192
0.680
Why?
Acid Anhydride Hydrolases
1
2018
13
0.680
Why?
Animals
79
2021
26414
0.680
Why?
Neoplasm Proteins
4
2017
532
0.670
Why?
Proteomics
2
2017
209
0.660
Why?
Oligonucleotide Array Sequence Analysis
8
2011
684
0.660
Why?
Male
69
2023
40659
0.660
Why?
Drug Synergism
16
2017
303
0.660
Why?
Adaptor Proteins, Signal Transducing
4
2015
302
0.660
Why?
Ifosfamide
4
2020
49
0.640
Why?
Liver
15
2005
1223
0.640
Why?
Transfection
14
2007
894
0.620
Why?
Electroporation
3
2001
55
0.600
Why?
CHO Cells
10
2007
187
0.590
Why?
Drug Therapy
4
2011
70
0.580
Why?
Antigens, CD34
3
2001
158
0.580
Why?
Carboxylic Ester Hydrolases
3
2002
23
0.570
Why?
Hematopoietic Stem Cells
4
2006
291
0.570
Why?
Fluorouracil
7
2014
556
0.570
Why?
Risk Factors
9
2023
5366
0.570
Why?
Carboxylesterase
3
2004
10
0.540
Why?
Cells, Cultured
8
2021
2798
0.540
Why?
Proteins
5
2014
775
0.540
Why?
Female
64
2021
44181
0.540
Why?
Carrier Proteins
4
2015
672
0.530
Why?
Dose-Response Relationship, Drug
14
2018
1959
0.530
Why?
Glioma
6
2007
285
0.520
Why?
Glutamates
2
2011
89
0.520
Why?
Alternative Splicing
4
2012
201
0.510
Why?
Mice
38
2021
11193
0.510
Why?
Antibiotics, Antineoplastic
5
2014
110
0.510
Why?
DNA Damage
9
2011
362
0.510
Why?
Gene Dosage
3
2011
207
0.500
Why?
Deoxycytidine
2
2014
237
0.490
Why?
Breast Neoplasms
7
2020
2855
0.490
Why?
Cricetinae
13
2007
560
0.480
Why?
Repressor Proteins
1
2017
400
0.480
Why?
Haplotypes
4
2014
642
0.480
Why?
Adenocarcinoma
2
2018
1159
0.480
Why?
Glutathione
4
2004
103
0.470
Why?
Adult
31
2022
25442
0.470
Why?
RNA-Binding Proteins
2
2012
244
0.460
Why?
Adenine Nucleotides
1
2013
63
0.460
Why?
Arabinonucleosides
1
2013
39
0.460
Why?
Neuroblastoma
2
2014
373
0.460
Why?
DNA Methylation
7
2015
619
0.460
Why?
Homeodomain Proteins
1
2017
533
0.460
Why?
Glioblastoma
9
2014
253
0.440
Why?
Child
14
2021
6866
0.440
Why?
Universities
1
2013
135
0.440
Why?
Colonic Neoplasms
10
1999
550
0.440
Why?
Inhibitory Concentration 50
6
2011
64
0.430
Why?
Drug Resistance
11
2018
256
0.430
Why?
Cortactin
1
2011
11
0.420
Why?
DNA Repair Enzymes
3
2014
52
0.420
Why?
Genomics
5
2014
702
0.420
Why?
Anti-Bacterial Agents
1
2017
732
0.410
Why?
Genealogy and Heraldry
1
2011
13
0.410
Why?
Inactivation, Metabolic
1
2011
8
0.410
Why?
Microsomes, Liver
5
2015
49
0.410
Why?
Lomustine
9
1992
26
0.400
Why?
Aged
27
2020
18254
0.400
Why?
Membrane Transport Proteins
1
2012
166
0.400
Why?
Gene Frequency
6
2017
675
0.390
Why?
Platinum Compounds
3
2010
30
0.390
Why?
Neoplasm Recurrence, Local
6
2017
1289
0.390
Why?
Follow-Up Studies
7
2020
3608
0.390
Why?
Epigenesis, Genetic
3
2013
466
0.390
Why?
Chromosome Mapping
5
2014
1070
0.380
Why?
Pharmaceutical Preparations
2
2011
92
0.380
Why?
Middle Aged
30
2020
24842
0.380
Why?
Transcriptome
5
2015
573
0.380
Why?
RNA, Messenger
7
2014
1974
0.380
Why?
Cell Cycle
5
2004
502
0.370
Why?
Aldehyde Dehydrogenase
1
2009
14
0.370
Why?
Databases, Genetic
6
2012
259
0.370
Why?
Linkage Disequilibrium
6
2013
473
0.360
Why?
Central Nervous System Neoplasms
5
2003
80
0.360
Why?
Genes, Regulator
1
2009
65
0.360
Why?
Promoter Regions, Genetic
7
2014
932
0.360
Why?
Capecitabine
4
2020
87
0.360
Why?
Mice, Nude
18
2005
788
0.350
Why?
Biomedical Research
1
2013
373
0.350
Why?
Folic Acid
1
2009
58
0.340
Why?
Hyaluronan Receptors
1
2009
36
0.340
Why?
Lymphocyte Activation
1
2012
722
0.340
Why?
Inheritance Patterns
1
2008
48
0.340
Why?
DNA
14
2011
1290
0.330
Why?
Cell Transformation, Neoplastic
3
2008
427
0.330
Why?
DNA Copy Number Variations
1
2009
171
0.330
Why?
Young Adult
9
2021
5918
0.330
Why?
Cation Transport Proteins
1
2008
64
0.330
Why?
B-Lymphocytes
1
2013
722
0.320
Why?
Gene Silencing
2
2015
172
0.320
Why?
Sex Characteristics
2
2009
312
0.320
Why?
Population
1
2008
35
0.320
Why?
Phosphoramide Mustards
3
2004
4
0.320
Why?
RNA, Small Interfering
4
2015
547
0.320
Why?
Pyrazines
2
2000
84
0.320
Why?
Chromosomes, Human
1
2008
66
0.320
Why?
Anticarcinogenic Agents
2
2000
70
0.320
Why?
Antigens, Differentiation
2
2005
140
0.310
Why?
Comprehension
1
2008
79
0.310
Why?
Prognosis
9
2020
3653
0.310
Why?
Survivors
3
2022
225
0.310
Why?
Exons
5
2012
450
0.310
Why?
Gene Expression Regulation, Leukemic
2
2021
90
0.310
Why?
Lung Neoplasms
4
2021
2248
0.300
Why?
Signal Transduction
5
2014
3222
0.300
Why?
Cell Division
11
2003
696
0.300
Why?
Tumor Suppressor Proteins
4
2014
279
0.300
Why?
Geographic Information Systems
1
2006
20
0.300
Why?
Methylnitronitrosoguanidine
7
1991
16
0.290
Why?
Endoplasmic Reticulum
1
2008
250
0.290
Why?
Alkyl and Aryl Transferases
4
1999
15
0.290
Why?
Colorectal Neoplasms
4
2014
919
0.290
Why?
Spermine
2
1998
17
0.290
Why?
Transplantation, Heterologous
16
2007
362
0.290
Why?
Mutation
9
2008
3946
0.280
Why?
Genome
2
2006
369
0.280
Why?
Biomarkers
3
2021
1701
0.280
Why?
Mycosis Fungoides
2
2011
23
0.280
Why?
Computational Biology
7
2014
528
0.280
Why?
Neoplasm Transplantation
14
2002
388
0.280
Why?
Health Status
1
2008
358
0.270
Why?
Adolescent
8
2021
8905
0.270
Why?
Rats
21
2015
3966
0.270
Why?
Mitomycin
1
2005
29
0.270
Why?
Kinetics
13
2003
1512
0.270
Why?
Models, Biological
5
2018
1740
0.260
Why?
Head and Neck Neoplasms
8
2011
1047
0.260
Why?
CDC2-CDC28 Kinases
1
2004
7
0.260
Why?
Ovarian Neoplasms
1
2011
737
0.250
Why?
Cytochrome P-450 CYP1A2
2
2001
4
0.250
Why?
Cell Death
4
2011
255
0.250
Why?
Platinum
3
2011
62
0.240
Why?
Chromatography, High Pressure Liquid
6
1999
313
0.240
Why?
Tubulin
2
2015
58
0.240
Why?
RNA Interference
3
2014
367
0.240
Why?
Case-Control Studies
6
2020
1796
0.230
Why?
Tissue Distribution
6
2004
290
0.230
Why?
Biotransformation
6
2009
50
0.230
Why?
Mesylates
5
1991
15
0.230
Why?
Survival Analysis
3
2006
1535
0.230
Why?
Proteome
2
2014
123
0.230
Why?
Chromosomes, Human, X
2
2015
55
0.230
Why?
Base Sequence
10
2014
2326
0.230
Why?
Treatment Outcome
11
2013
7908
0.230
Why?
Prodrugs
2
2004
46
0.230
Why?
Microtubule-Associated Proteins
2
2015
176
0.220
Why?
Leukemia
4
2009
317
0.220
Why?
Cytosol
4
2011
189
0.220
Why?
Astrocytoma
2
2000
82
0.220
Why?
Xenograft Model Antitumor Assays
3
2021
458
0.220
Why?
Sensation Disorders
1
2022
23
0.210
Why?
Cohort Studies
3
2021
2738
0.210
Why?
Quantitative Trait, Heritable
2
2013
124
0.210
Why?
Speech
1
2022
84
0.210
Why?
Blotting, Western
6
2011
779
0.210
Why?
Apoptosis Regulatory Proteins
2
2013
199
0.210
Why?
Hypercholesterolemia
1
2023
161
0.210
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2011
874
0.200
Why?
Methylnitrosourea
4
1989
7
0.200
Why?
Antibodies
3
2014
350
0.200
Why?
Survival Rate
4
2020
1855
0.200
Why?
Hydrolysis
4
2004
141
0.200
Why?
CpG Islands
4
2015
148
0.200
Why?
Primary Cell Culture
1
2021
72
0.200
Why?
Drug Interactions
5
2005
248
0.200
Why?
Adaptor Proteins, Vesicular Transport
1
2021
49
0.200
Why?
Oligodeoxyribonucleotides
4
1988
126
0.200
Why?
Drug Administration Schedule
7
2009
917
0.200
Why?
Codon
2
1999
124
0.200
Why?
Kidney
6
2013
1226
0.190
Why?
Vinblastine
1
2020
108
0.190
Why?
Fetal Blood
1
2001
90
0.190
Why?
Gene Knockdown Techniques
1
2021
234
0.190
Why?
Gene Transfer Techniques
1
2001
152
0.190
Why?
Bleomycin
1
2020
98
0.190
Why?
Deoxycytidine Kinase
2
2011
4
0.190
Why?
Cell Differentiation
2
2017
1434
0.190
Why?
Oxidoreductases
3
1999
111
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2002
151
0.190
Why?
Ketoconazole
1
2000
25
0.190
Why?
Mice, Inbred BALB C
11
2005
1042
0.180
Why?
Genetic Testing
2
2017
530
0.180
Why?
Colonic Polyps
1
2000
126
0.180
Why?
Escherichia coli
7
1993
595
0.170
Why?
Myosin Heavy Chains
1
2019
88
0.170
Why?
Myosin Type II
1
2019
48
0.170
Why?
RNA, Ribosomal, 16S
1
2020
241
0.170
Why?
Hypogonadism
1
2019
37
0.170
Why?
Isoenzymes
4
2001
271
0.170
Why?
Antigens, CD
1
2001
457
0.170
Why?
Radiotherapy
2
2020
326
0.170
Why?
Taxoids
2
2016
129
0.170
Why?
Time Factors
11
2014
5186
0.170
Why?
Mice, Inbred C57BL
6
2016
3070
0.170
Why?
Area Under Curve
4
2008
333
0.170
Why?
Genital Neoplasms, Female
1
2020
107
0.170
Why?
Vagina
1
2020
162
0.170
Why?
Structure-Activity Relationship
8
2001
407
0.170
Why?
Naphthoquinones
1
1998
5
0.170
Why?
Linear Models
2
2011
416
0.170
Why?
Pyrimidines
3
1996
370
0.160
Why?
Aged, 80 and over
10
2020
6464
0.160
Why?
Molecular Sequence Data
9
2011
3027
0.160
Why?
Protein Isoforms
3
2012
269
0.160
Why?
Self Report
1
2019
280
0.150
Why?
Recombinant Proteins
6
2007
1012
0.150
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2009
71
0.150
Why?
Cyclin-Dependent Kinase 2
2
2009
25
0.150
Why?
Herpesvirus 4, Human
2
2010
114
0.150
Why?
Bacteria
2
2020
441
0.150
Why?
Drug Screening Assays, Antitumor
6
2014
78
0.150
Why?
Medulloblastoma
5
2005
36
0.150
Why?
Age of Onset
1
2017
306
0.140
Why?
Cell Line, Transformed
2
2008
153
0.140
Why?
Ethylnitrosourea
2
1988
29
0.140
Why?
DNA Modification Methylases
2
2014
25
0.140
Why?
Quality of Life
4
2020
1551
0.140
Why?
Mutagenicity Tests
3
2006
6
0.140
Why?
Streptozocin
7
1994
54
0.140
Why?
Child, Preschool
6
2015
3598
0.140
Why?
Polyneuropathies
1
2016
27
0.140
Why?
Real-Time Polymerase Chain Reaction
2
2014
269
0.140
Why?
Neoplasms, Germ Cell and Embryonal
1
2016
47
0.140
Why?
Introns
3
2012
288
0.140
Why?
Mice, Knockout
3
2016
1908
0.140
Why?
Proto-Oncogene Proteins c-bcr
1
2015
7
0.140
Why?
X Chromosome Inactivation
1
2015
28
0.130
Why?
Half-Life
3
2003
96
0.130
Why?
Thymine
4
1988
17
0.130
Why?
Epistasis, Genetic
2
2013
85
0.130
Why?
Flow Cytometry
3
2003
674
0.130
Why?
Rats, Sprague-Dawley
6
2000
1209
0.130
Why?
Acrolein
2
2007
4
0.130
Why?
Acetaldehyde
2
2007
7
0.130
Why?
Neurites
1
2015
35
0.130
Why?
Databases, Nucleic Acid
1
2015
41
0.130
Why?
Pedigree
2
2008
965
0.130
Why?
Treatment Failure
2
2014
284
0.130
Why?
DEAD-box RNA Helicases
1
2015
62
0.130
Why?
Oxygenases
1
2014
13
0.130
Why?
Glutathione S-Transferase pi
1
2014
18
0.130
Why?
Deoxyguanosine
3
2004
28
0.130
Why?
Prostatic Neoplasms, Castration-Resistant
1
2016
104
0.130
Why?
Kaplan-Meier Estimate
3
2012
857
0.130
Why?
Hand-Foot Syndrome
1
2014
1
0.130
Why?
Body Weight
4
2013
458
0.130
Why?
Skin Neoplasms
1
1999
541
0.130
Why?
Cyclohexylamines
1
2014
7
0.120
Why?
Infusions, Intravenous
3
2007
430
0.120
Why?
Cricetulus
3
2007
126
0.120
Why?
Adjuvants, Pharmaceutic
1
1994
5
0.120
Why?
Sequence Analysis, RNA
1
2015
216
0.120
Why?
Prostatic Neoplasms
2
1998
1696
0.120
Why?
HEK293 Cells
2
2013
615
0.120
Why?
Plicamycin
1
2013
9
0.120
Why?
Eye Proteins
1
2015
128
0.120
Why?
DNA Mismatch Repair
2
2011
52
0.120
Why?
Carcinoma
2
1989
432
0.120
Why?
5' Untranslated Regions
2
2004
49
0.120
Why?
Ribonucleoside Diphosphate Reductase
1
2013
6
0.120
Why?
Glycerol
1
1994
32
0.120
Why?
Quality Control
1
2014
117
0.120
Why?
Epithelial Cells
1
2018
662
0.120
Why?
DNA-Binding Proteins
4
2014
1204
0.120
Why?
Amino Acid Sequence
5
2005
2060
0.120
Why?
Population Surveillance
2
2012
219
0.120
Why?
Cell Cycle Checkpoints
1
2013
63
0.120
Why?
Healthcare Disparities
1
2017
361
0.110
Why?
Regulatory Factor X Transcription Factors
1
2012
11
0.110
Why?
Interleukin-11
1
2013
19
0.110
Why?
Injections, Intravenous
4
2006
243
0.110
Why?
Methylation
6
2011
251
0.110
Why?
Alleles
3
2005
1124
0.110
Why?
3' Untranslated Regions
2
2004
92
0.110
Why?
Caspase 1
1
2012
18
0.110
Why?
Salmonella Infections
1
2012
18
0.110
Why?
Risk Assessment
4
2014
2243
0.110
Why?
Multifactorial Inheritance
1
2014
153
0.110
Why?
Salmonella typhimurium
1
2012
31
0.110
Why?
Tubulin Modulators
1
2012
24
0.110
Why?
Hypoxanthine Phosphoribosyltransferase
2
2008
35
0.110
Why?
Age Factors
1
2017
1831
0.110
Why?
In Vitro Techniques
5
2015
986
0.110
Why?
Methionine
1
2012
66
0.110
Why?
Mutagenesis
2
2008
199
0.110
Why?
Students
1
2013
146
0.110
Why?
Nigeria
1
2012
152
0.110
Why?
Electrophoresis, Polyacrylamide Gel
3
2002
268
0.100
Why?
Floxuridine
1
2011
11
0.100
Why?
Southwestern United States
1
2011
8
0.100
Why?
Sezary Syndrome
1
2011
8
0.100
Why?
5'-Nucleotidase
1
2011
13
0.100
Why?
Germ Cells
1
2012
120
0.100
Why?
Myeloid-Lymphoid Leukemia Protein
2
2009
72
0.100
Why?
DNA Breaks, Double-Stranded
2
2009
63
0.100
Why?
Twins, Monozygotic
1
2011
57
0.100
Why?
Polyethylene Glycols
1
1994
361
0.100
Why?
Interleukin-3
2
2001
36
0.100
Why?
Microfilament Proteins
1
2013
206
0.100
Why?
Drug Labeling
1
2011
41
0.100
Why?
Protein-Tyrosine Kinases
1
2013
302
0.100
Why?
Caspases
1
2011
155
0.100
Why?
DNA, Complementary
2
2002
392
0.100
Why?
Disease-Free Survival
1
2014
1203
0.100
Why?
Maximum Tolerated Dose
3
2008
270
0.100
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2001
111
0.100
Why?
United States Food and Drug Administration
1
2011
126
0.100
Why?
HeLa Cells
3
1988
498
0.100
Why?
Loss of Heterozygosity
3
2007
85
0.100
Why?
Cluster Analysis
4
2013
363
0.090
Why?
Escherichia coli Proteins
1
1991
179
0.090
Why?
Cell Culture Techniques
2
2001
187
0.090
Why?
Mutagens
2
2000
31
0.090
Why?
Semustine
1
1990
2
0.090
Why?
Rhabdomyosarcoma
2
2003
40
0.090
Why?
Vinca Alkaloids
1
2009
3
0.090
Why?
Neutropenia
2
2009
214
0.090
Why?
Polymerase Chain Reaction
2
2004
926
0.090
Why?
Topoisomerase II Inhibitors
3
2011
26
0.090
Why?
Software
2
2014
651
0.090
Why?
Open Reading Frames
1
2009
117
0.090
Why?
Anthracyclines
1
2009
37
0.090
Why?
Amino Acid Transport Systems, Basic
1
2008
1
0.090
Why?
Recombinant Fusion Proteins
2
2001
553
0.090
Why?
Semaphorins
1
2008
17
0.090
Why?
Copper-transporting ATPases
1
2008
12
0.090
Why?
Protein-Arginine N-Methyltransferases
1
2008
12
0.090
Why?
RNA Precursors
1
2009
69
0.090
Why?
Genetic Markers
1
2010
476
0.090
Why?
Metabolic Networks and Pathways
1
2009
77
0.090
Why?
Multidrug Resistance-Associated Proteins
3
2009
27
0.090
Why?
Models, Genetic
3
2014
926
0.090
Why?
Lod Score
1
2008
150
0.090
Why?
Glypicans
1
2008
6
0.090
Why?
Caspase 12
1
2008
1
0.080
Why?
Adenosine Triphosphate
1
2010
308
0.080
Why?
Chicago
1
2013
1366
0.080
Why?
Transcription Factor CHOP
1
2008
15
0.080
Why?
Thiones
2
2000
10
0.080
Why?
Mitogen-Activated Protein Kinase 1
1
2008
74
0.080
Why?
Cytochrome P-450 CYP1B1
1
2008
9
0.080
Why?
Epoxide Hydrolases
1
2008
7
0.080
Why?
Neurofibromin 1
1
2008
8
0.080
Why?
Hypertension
1
2017
1134
0.080
Why?
Models, Theoretical
1
2011
476
0.080
Why?
RNA Processing, Post-Transcriptional
1
2009
105
0.080
Why?
Melphalan
2
2001
97
0.080
Why?
Cross-Linking Reagents
1
1988
86
0.080
Why?
Thiophenes
2
2000
48
0.080
Why?
Benzimidazoles
1
2009
140
0.080
Why?
Caspase 3
1
2008
159
0.080
Why?
Aryl Hydrocarbon Hydroxylases
1
2008
44
0.080
Why?
Nucleic Acid Conformation
1
2009
332
0.080
Why?
Drug Delivery Systems
2
2007
177
0.080
Why?
Diabetes Mellitus
1
1996
798
0.080
Why?
Peptides
1
1991
639
0.080
Why?
Electronic Health Records
1
2011
317
0.080
Why?
Biological Availability
2
2000
91
0.080
Why?
Biological Transport
1
2008
395
0.080
Why?
Adenosine Triphosphatases
1
2008
153
0.080
Why?
Reproducibility of Results
4
2013
2680
0.080
Why?
Oxazines
1
2007
13
0.080
Why?
Obesity
1
2014
955
0.080
Why?
Xanthenes
1
2007
23
0.080
Why?
Transcription Factor RelA
1
2007
49
0.080
Why?
Proto-Oncogene Proteins B-raf
1
2008
137
0.080
Why?
Gene Deletion
1
2008
328
0.080
Why?
Fibroblasts
3
2008
728
0.080
Why?
Hematopoiesis
1
2008
163
0.080
Why?
Oncogenes
1
2007
88
0.080
Why?
Mice, Transgenic
2
2006
1530
0.080
Why?
DNA Adducts
2
2009
20
0.080
Why?
Nitrosourea Compounds
2
2002
9
0.070
Why?
Regression Analysis
1
2008
593
0.070
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2008
171
0.070
Why?
Binding Sites
2
2003
1097
0.070
Why?
Disease Models, Animal
2
2013
2218
0.070
Why?
Administration, Oral
2
2000
684
0.070
Why?
United States
3
2017
6585
0.070
Why?
Nitrosamines
2
1988
8
0.070
Why?
Oxidation-Reduction
2
1998
372
0.070
Why?
Leukocytes, Mononuclear
2
1998
196
0.070
Why?
Alkylation
5
2004
31
0.070
Why?
Thymidine
1
1985
58
0.070
Why?
Activin Receptors, Type I
1
2005
12
0.070
Why?
Substrate Specificity
6
1995
347
0.070
Why?
Protein Phosphatase 1
1
2005
34
0.070
Why?
Physicians
1
2013
668
0.070
Why?
Base Pair Mismatch
1
2005
27
0.070
Why?
Carcinoma, Hepatocellular
2
2003
376
0.070
Why?
Receptors, Transforming Growth Factor beta
1
2005
40
0.070
Why?
Nerve Tissue Proteins
1
2008
502
0.070
Why?
Bacterial Proteins
1
1991
861
0.070
Why?
Neoplasms, Experimental
1
2007
269
0.070
Why?
Crosses, Genetic
1
2005
169
0.070
Why?
Cell Transformation, Viral
1
2005
40
0.070
Why?
Mice, Mutant Strains
1
2005
228
0.070
Why?
Doxorubicin
2
2013
288
0.070
Why?
Random Allocation
1
2005
332
0.060
Why?
Glutathione Peroxidase
1
2004
24
0.060
Why?
Dimethylnitrosamine
1
1984
4
0.060
Why?
Diethylnitrosamine
1
1984
7
0.060
Why?
Polydeoxyribonucleotides
1
1984
5
0.060
Why?
Aziridines
1
2004
9
0.060
Why?
Poly T
1
1984
2
0.060
Why?
Procaine
1
2004
11
0.060
Why?
Clinical Trials as Topic
4
2014
1166
0.060
Why?
Organ Size
1
2005
362
0.060
Why?
Protein Kinase Inhibitors
1
2009
588
0.060
Why?
Cattle
3
1999
372
0.060
Why?
Sequence Homology, Amino Acid
2
2003
415
0.060
Why?
Hydroxamic Acids
1
2004
49
0.060
Why?
Plasmids
2
2003
283
0.060
Why?
Odds Ratio
2
2019
675
0.060
Why?
Germ-Line Mutation
2
2020
323
0.060
Why?
Homozygote
1
2004
200
0.060
Why?
Computer Simulation
1
2009
1073
0.060
Why?
Sarcoma
1
2006
210
0.060
Why?
NF-kappa B
1
2007
440
0.060
Why?
Drug Combinations
1
2004
221
0.060
Why?
Genes, ras
3
2009
96
0.060
Why?
Gene Expression Regulation, Enzymologic
2
2003
211
0.060
Why?
Protein Kinases
1
2005
207
0.060
Why?
Annexin A5
1
2003
20
0.060
Why?
Indoles
1
2005
317
0.060
Why?
Transcription Initiation Site
1
2003
45
0.060
Why?
Chromosomes, Human, Pair 16
1
2003
79
0.060
Why?
DNA Primers
3
2005
541
0.060
Why?
Lung
2
2005
1149
0.060
Why?
Microscopy, Fluorescence
2
2007
424
0.060
Why?
Subcellular Fractions
2
2007
93
0.060
Why?
Isoelectric Focusing
1
2002
39
0.060
Why?
Protein Synthesis Inhibitors
1
2002
36
0.060
Why?
Dihydrouracil Dehydrogenase (NADP)
3
1999
29
0.060
Why?
DNA Topoisomerases, Type II
2
2009
19
0.050
Why?
Gene Library
1
2002
130
0.050
Why?
Infant
4
2012
3029
0.050
Why?
Chlorambucil
1
2001
23
0.050
Why?
ErbB Receptors
1
2005
485
0.050
Why?
Thrombopoietin
1
2001
12
0.050
Why?
Stem Cell Factor
1
2001
19
0.050
Why?
Body Mass Index
2
2014
765
0.050
Why?
Prospective Studies
2
2020
4156
0.050
Why?
Organ Specificity
2
2001
257
0.050
Why?
A549 Cells
1
2021
39
0.050
Why?
Cloning, Molecular
1
2002
646
0.050
Why?
Colony-Forming Units Assay
1
2001
40
0.050
Why?
NAD+ Nucleosidase
1
2001
2
0.050
Why?
ADP-ribosyl Cyclase
1
2001
6
0.050
Why?
Chemotherapy, Adjuvant
3
2017
458
0.050
Why?
ADP-ribosyl Cyclase 1
1
2001
12
0.050
Why?
Salvage Therapy
1
2002
232
0.050
Why?
Plasma
1
2001
50
0.050
Why?
Nervous System Neoplasms
1
2000
11
0.050
Why?
Immunophenotyping
1
2001
211
0.050
Why?
Risk
2
2012
672
0.050
Why?
Biopsy
2
2003
1159
0.050
Why?
Ferredoxin-NADP Reductase
1
2020
15
0.050
Why?
Genes, Reporter
1
2001
266
0.050
Why?
Luminescent Proteins
1
2001
143
0.050
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2020
26
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2001
164
0.050
Why?
Phenanthridines
1
2000
24
0.050
Why?
Genetic Association Studies
2
2013
292
0.050
Why?
Green Fluorescent Proteins
1
2001
304
0.050
Why?
Molecular Structure
2
1998
287
0.050
Why?
Hot Temperature
1
2000
205
0.050
Why?
Transferases
2
1997
24
0.050
Why?
Immunomagnetic Separation
1
1999
8
0.050
Why?
Azoxymethane
1
1999
82
0.050
Why?
Rectum
1
2000
142
0.050
Why?
Cell Nucleus
2
1999
578
0.050
Why?
Electrochemistry
1
1999
61
0.040
Why?
Carcinogens
1
1999
108
0.040
Why?
Luciferases
2
2011
118
0.040
Why?
Sequence Alignment
1
2000
350
0.040
Why?
Uracil
1
1999
70
0.040
Why?
Models, Statistical
2
2014
573
0.040
Why?
Prevalence
1
2023
1230
0.040
Why?
Patient Outcome Assessment
1
2019
83
0.040
Why?
Drug Resistance, Multiple
1
1998
20
0.040
Why?
Peroxidases
1
1998
34
0.040
Why?
Transcription, Genetic
1
2003
1127
0.040
Why?
bcl-X Protein
1
1998
52
0.040
Why?
Membrane Glycoproteins
1
2001
428
0.040
Why?
Esters
1
1998
29
0.040
Why?
Protein Binding
2
2007
1450
0.040
Why?
Multivariate Analysis
2
2012
995
0.040
Why?
Molecular Sequence Annotation
1
2018
67
0.040
Why?
Carcinoma, Renal Cell
1
2002
420
0.040
Why?
Patient Reported Outcome Measures
1
2019
156
0.040
Why?
Macaca mulatta
1
2000
458
0.040
Why?
Datasets as Topic
1
2017
71
0.040
Why?
ATP-Binding Cassette Transporters
1
1998
141
0.040
Why?
Thymidylate Synthase
1
1997
13
0.040
Why?
Tumor Stem Cell Assay
3
2009
35
0.040
Why?
Injections, Intraperitoneal
2
1994
102
0.040
Why?
Leukemia P388
2
1989
3
0.040
Why?
Proto-Oncogene Proteins c-bcl-2
1
1998
189
0.040
Why?
Swine
1
1998
551
0.040
Why?
Speech Reception Threshold Test
1
2016
4
0.040
Why?
Hearing Loss, Noise-Induced
1
2016
4
0.040
Why?
Kidney Neoplasms
1
2002
614
0.040
Why?
Auditory Threshold
1
2016
17
0.040
Why?
CD4-Positive T-Lymphocytes
1
1999
418
0.040
Why?
Audiometry, Pure-Tone
1
2016
24
0.040
Why?
Neoplasms, Squamous Cell
1
1996
19
0.040
Why?
Drug Evaluation, Preclinical
2
1989
103
0.040
Why?
Rats, Inbred Strains
2
1988
312
0.040
Why?
Receptor, ErbB-2
1
2017
210
0.040
Why?
Hearing Loss, Conductive
1
2016
17
0.040
Why?
Phenobarbital
1
1995
33
0.030
Why?
Receptors, Estrogen
1
2017
380
0.030
Why?
Guideline Adherence
1
2017
221
0.030
Why?
Enzyme Induction
1
1995
88
0.030
Why?
Breast
1
2017
285
0.030
Why?
Azepines
1
2015
20
0.030
Why?
RNA, Transfer
2
1988
151
0.030
Why?
Cytochrome P-450 CYP2B6
1
2015
6
0.030
Why?
Lymph Nodes
1
1999
529
0.030
Why?
Cytochrome P-450 CYP2C19
1
2015
7
0.030
Why?
Prednisone
1
2016
255
0.030
Why?
Hydroxylation
1
2015
16
0.030
Why?
Cytochrome P-450 CYP2C9
1
2015
21
0.030
Why?
Deuterium
1
2015
33
0.030
Why?
Pharmacogenomic Testing
1
2016
96
0.030
Why?
Cytochrome P-450 CYP3A
1
2015
43
0.030
Why?
Isotope Labeling
1
2015
51
0.030
Why?
Neural Stem Cells
1
2015
58
0.030
Why?
Patient Acceptance of Health Care
1
2017
234
0.030
Why?
Bevacizumab
1
2016
279
0.030
Why?
Catalysis
1
2015
203
0.030
Why?
Triazoles
1
2015
96
0.030
Why?
Predictive Value of Tests
3
2008
1664
0.030
Why?
DNA Polymerase II
1
1994
7
0.030
Why?
DNA Polymerase I
1
1994
9
0.030
Why?
Sensitivity and Specificity
1
1999
1979
0.030
Why?
Metabolic Clearance Rate
1
2014
121
0.030
Why?
Protein Array Analysis
1
2014
50
0.030
Why?
Cell Growth Processes
1
2014
83
0.030
Why?
Genetics, Medical
1
2014
50
0.030
Why?
Body Composition
1
2014
68
0.030
Why?
Databases, Factual
1
2017
799
0.030
Why?
Absorptiometry, Photon
1
2014
97
0.030
Why?
Systems Biology
1
2014
42
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2016
377
0.030
Why?
Registries
1
2017
698
0.030
Why?
Idoxuridine
1
1993
16
0.030
Why?
Neoplasm Staging
1
2019
1929
0.030
Why?
Species Specificity
2
1993
678
0.030
Why?
Cladribine
1
2013
35
0.030
Why?
Dimethylhydrazines
1
1993
2
0.030
Why?
Simvastatin
1
2014
106
0.030
Why?
Galectin 3
1
2013
17
0.030
Why?
Proliferating Cell Nuclear Antigen
1
2013
66
0.030
Why?
In Situ Nick-End Labeling
1
2013
121
0.030
Why?
Solubility
1
1994
176
0.030
Why?
Azacitidine
1
2014
136
0.030
Why?
Suppression, Genetic
1
2013
30
0.030
Why?
Cysteine
1
1993
131
0.030
Why?
RNA Isoforms
1
2012
5
0.030
Why?
Necrosis
1
2013
200
0.030
Why?
Interferon-alpha
3
2000
232
0.030
Why?
GATA3 Transcription Factor
1
2013
47
0.030
Why?
Kidney Tubules
1
2013
94
0.030
Why?
Cholesterol, LDL
1
2014
222
0.030
Why?
Pilot Projects
1
1995
834
0.030
Why?
Cyclin-Dependent Kinases
1
2012
43
0.030
Why?
Thionucleosides
1
2012
8
0.030
Why?
Epithelial-Mesenchymal Transition
1
2013
69
0.030
Why?
Carcinoma, Squamous Cell
1
2000
1075
0.030
Why?
Caspase 9
1
2012
47
0.030
Why?
Deoxyadenosines
1
2012
23
0.030
Why?
Chromatin
1
2015
366
0.030
Why?
Purines
1
1992
91
0.030
Why?
Bayes Theorem
1
2014
357
0.030
Why?
Models, Neurological
1
2015
405
0.030
Why?
Gene-Environment Interaction
1
2013
100
0.030
Why?
Histones
1
2014
305
0.030
Why?
Cell Hypoxia
1
1993
164
0.030
Why?
Cell-Free System
1
1991
51
0.030
Why?
Double-Blind Method
1
2016
1812
0.030
Why?
DNA, Single-Stranded
1
1992
92
0.030
Why?
Melanoma
1
1996
451
0.030
Why?
MutL Protein Homolog 1
1
2011
33
0.030
Why?
MutS Homolog 2 Protein
1
2011
30
0.030
Why?
Electrophoretic Mobility Shift Assay
1
2011
72
0.030
Why?
Cytoskeleton
1
2013
190
0.030
Why?
Cardiovascular Diseases
2
2010
823
0.030
Why?
Bone Marrow Cells
1
2012
251
0.030
Why?
Drug Therapy, Combination
2
1995
894
0.030
Why?
Immunohistochemistry
3
2006
1751
0.030
Why?
Sequence Analysis, DNA
1
2014
852
0.020
Why?
Genes, X-Linked
1
2011
37
0.020
Why?
Paresthesia
1
2010
16
0.020
Why?
Severity of Illness Index
1
2016
1773
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
1991
377
0.020
Why?
Infertility, Male
1
2010
24
0.020
Why?
Employment
1
2010
52
0.020
Why?
Enzyme Activation
1
1991
692
0.020
Why?
Tissue Extracts
1
1990
24
0.020
Why?
Thrombocytopenia
2
2006
181
0.020
Why?
Mitoguazone
1
1989
2
0.020
Why?
Randomized Controlled Trials as Topic
1
2014
843
0.020
Why?
Protein Conformation
1
2012
881
0.020
Why?
Mass Spectrometry
1
1990
188
0.020
Why?
Neoplasm Metastasis
2
2005
1053
0.020
Why?
Thermodynamics
1
2010
308
0.020
Why?
Combined Modality Therapy
3
2000
1657
0.020
Why?
Renal Insufficiency
1
2010
113
0.020
Why?
RUNX1 Translocation Partner 1 Protein
1
2009
8
0.020
Why?
Mice, Inbred Strains
1
1990
304
0.020
Why?
Liver Neoplasms
1
1995
712
0.020
Why?
Glucuronides
1
2009
34
0.020
Why?
Fatigue
1
2010
173
0.020
Why?
Organic Anion Transporters
1
2009
27
0.020
Why?
Magnetic Resonance Spectroscopy
1
1990
315
0.020
Why?
Core Binding Factor Alpha 2 Subunit
1
2009
52
0.020
Why?
Research Design
1
2012
589
0.020
Why?
Bilirubin
1
2009
124
0.020
Why?
Hepatocyte Nuclear Factor 1-alpha
1
2009
79
0.020
Why?
Pulmonary Fibrosis
1
2010
120
0.020
Why?
Disease Progression
2
2005
1519
0.020
Why?
Calcium
1
1993
1143
0.020
Why?
Oncogene Proteins, Fusion
1
2009
128
0.020
Why?
Ovary
1
1989
250
0.020
Why?
Thiosemicarbazones
1
2008
6
0.020
Why?
Methemoglobinemia
1
2008
10
0.020
Why?
Drug Hypersensitivity
1
2008
38
0.020
Why?
DNA Glycosylases
1
1988
24
0.020
Why?
Models, Molecular
1
2012
1283
0.020
Why?
Glucuronosyltransferase
1
2009
184
0.020
Why?
Microsatellite Instability
1
2007
40
0.020
Why?
Evidence-Based Medicine
1
2010
426
0.020
Why?
Neoplasms, Second Primary
1
2010
252
0.020
Why?
Informatics
1
2007
5
0.020
Why?
Tetradecanoylphorbol Acetate
1
2007
137
0.020
Why?
Active Transport, Cell Nucleus
1
2007
75
0.020
Why?
Antigens, Neoplasm
1
2009
324
0.020
Why?
Retrospective Studies
2
2017
8342
0.020
Why?
Drug Monitoring
1
2008
118
0.020
Why?
Forecasting
1
2008
303
0.020
Why?
RNA, Ribosomal
1
1987
60
0.020
Why?
Reference Values
1
2008
672
0.020
Why?
Hydroxyurea
2
2000
239
0.020
Why?
Cardiovascular Agents
1
2007
56
0.020
Why?
Tumor Suppressor Protein p53
1
2009
378
0.020
Why?
Translocation, Genetic
1
2007
265
0.020
Why?
Leucovorin
2
1997
218
0.020
Why?
Tachycardia, Supraventricular
1
2006
16
0.020
Why?
Gastrointestinal Stromal Tumors
1
2006
23
0.020
Why?
Cell Adhesion
1
2007
418
0.020
Why?
Poly (ADP-Ribose) Polymerase-1
1
2005
21
0.020
Why?
Platelet Aggregation Inhibitors
1
2007
131
0.020
Why?
Pyridines
1
2008
309
0.020
Why?
Leiomyosarcoma
1
2006
40
0.020
Why?
Genetics, Population
1
2008
394
0.020
Why?
Cognition
1
2010
563
0.020
Why?
Consensus Sequence
1
2005
64
0.020
Why?
Patient Selection
1
2009
683
0.020
Why?
Anemia
1
2006
128
0.020
Why?
Sequence Deletion
1
2005
203
0.020
Why?
Toxicity Tests
1
2004
13
0.020
Why?
Recurrence
1
2008
1132
0.020
Why?
Lung Diseases
1
2007
261
0.020
Why?
Rhabdomyosarcoma, Alveolar
1
2003
4
0.020
Why?
Leukemia L1210
1
1983
12
0.020
Why?
Rhabdomyosarcoma, Embryonal
1
2003
6
0.020
Why?
RNA
1
1988
557
0.010
Why?
Transforming Growth Factor beta
1
2005
297
0.010
Why?
Remission Induction
2
1997
721
0.010
Why?
Substance-Related Disorders
1
2007
387
0.010
Why?
Life Tables
1
2002
48
0.010
Why?
Algorithms
1
2010
1823
0.010
Why?
Selenoproteins
1
2001
19
0.010
Why?
Gliosarcoma
1
2000
7
0.010
Why?
Drug Implants
1
2000
34
0.010
Why?
Rats, Inbred F344
1
2000
156
0.010
Why?
Stereotaxic Techniques
1
2000
69
0.010
Why?
Benzophenanthridines
1
2000
23
0.010
Why?
Alkaloids
1
2000
45
0.010
Why?
Tretinoin
1
2000
125
0.010
Why?
Radiotherapy Dosage
1
2000
467
0.010
Why?
Protein Kinase C
1
2000
270
0.010
Why?
Cerebellar Neoplasms
1
1999
36
0.010
Why?
Rats, Nude
1
1997
22
0.010
Why?
Injections, Intra-Arterial
1
1997
33
0.010
Why?
Radiography
1
1999
809
0.010
Why?
Feasibility Studies
1
1999
750
0.010
Why?
Tetrahydrofolates
1
1996
13
0.010
Why?
Stereoisomerism
1
1996
102
0.010
Why?
Preoperative Care
1
1998
389
0.010
Why?
Fluorescent Antibody Technique, Indirect
1
1996
68
0.010
Why?
Cell Compartmentation
1
1996
69
0.010
Why?
Procarbazine
1
1995
40
0.010
Why?
Cytoplasm
1
1996
281
0.010
Why?
Bile
1
1994
57
0.010
Why?
Topotecan
1
1994
45
0.010
Why?
Protein Structure, Secondary
1
1995
329
0.010
Why?
Antimutagenic Agents
1
1993
6
0.010
Why?
Biogenic Polyamines
1
1993
1
0.010
Why?
Ornithine Decarboxylase
1
1993
8
0.010
Why?
Infant, Newborn
2
1991
2359
0.010
Why?
Monocytes
1
1994
214
0.010
Why?
Diploidy
1
1991
30
0.010
Why?
Saccharomyces cerevisiae
1
1995
434
0.010
Why?
Diet
1
1993
441
0.010
Why?
Colon
1
1993
492
0.010
Why?
DNA Mutational Analysis
1
1991
526
0.010
Why?
Image Processing, Computer-Assisted
1
1996
1198
0.010
Why?
N-Glycosyl Hydrolases
1
1988
7
0.010
Why?
Mammals
1
1988
225
0.000
Why?
Thymus Gland
1
1985
192
0.000
Why?
Skin
1
1985
553
0.000
Why?
Dolan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (798)
Explore
_
Co-Authors (52)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_